Baidu
map

2021年3月30日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2820万,病毒实现跨物种传播,为抗疫带来不确定性

2021-03-30 MedSci整理 MedSci整理

Worldometers世界实时统计数据显示,截至北京时间2021年3月30日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12820万例,新增414,976例,达到128,202,10

Worldometers世界实时统计数据显示,截至北京时间2021年3月30日7时01分,全球累计确诊新冠肺炎COVID-19)病例超过12820万例,新增414,976例,达到128,202,107例。累计死亡病例超280.3万例,达到2,803,537例,新增死亡为7,056例。康复为103,408,686例,重症和危重症病人达到93,670例;全球新冠确诊病例超过100万例的国家达21个,86个国家病例超10万例。美国新冠肺炎累计确诊病例全球最多,超过3102万例,达到31,027,973例,新增53,773例;累计死亡病例超过56.3万例,达到563,158例,新增死亡591例。巴西疫情昨日新增42,666例。目前全球接种疫苗5.52亿剂,其中美国接种1.434亿剂,中国接种1.066亿剂,欧盟接种6875万剂,印度接种6053万剂,英国接种3368万剂。昨日报道:2021年3月29日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2741万,直布罗陀超过90%人口接种新冠疫苗,已无疫情

全球疫苗接种剂次

Country
Cumulative COVID-19 vaccinationsdoses
World 552.00 million
Asia 231.41 million
North America 157.40 million
United States 143.46 million
Europe 118.20 million
China 106.61 million
European Union 68.75 million
India 60.53 million
South America 34.59 million
United Kingdom Mar 27, 2021 33.68 million
England Mar 27, 2021 28.33 million
Brazil 17.71 million
Turkey Mar 27, 2021 14.65 million
Germany 12.87 million
Russia Mar 22, 2021 10.60 million
Indonesia Mar 27, 2021 10.43 million
France Mar 27, 2021 10.39 million

全球约20个国家已出现3种变异新冠病毒

据日本共同社29日晚消息,英国相关机构调查后获悉,在英国发现的变异新冠病毒已扩散至全球100多个国家。而在南非和巴西发现的变异新冠病毒合计在约120个国家出现。全球约20个国家已同时出现这3种变异新冠病毒。

世界各国都在推进新冠疫苗接种工作。但随着各国不断发现变异新冠病毒,许多声音质疑目前的疫苗是否有效。现在,各家大型制药公司都在紧急推动疫苗改良工作。

截至目前,全球新冠确诊患者已超过1.27亿人,新冠疫情仍不见平息趋势。外媒称:“病毒通常会存在变异情况,如果不及时防止已有病毒的流行,我们不得不在将来面对威胁性更大的变异病毒。”

变异新冠病毒层出不穷!病毒突破物种屏障,全球抗疫面临不确定性

新变异病毒的名单还在不断增加。3月21日比利时媒体报道,列日大学检测出名为B.1.214的新冠病毒新变种,其呈现出此前从未发现的变异:该变异株的S蛋白RNA序列上增加了9个核苷酸。B.1.214目前约占比利时感染总数的4%,变异对该病毒的功能性影响尚不清楚。

为应对变异,研发和生产新型疫苗已经提上日程。法国总统马克龙于3月26日在电视讲话中称,病毒将继续存在、传播、变异,欧洲正在开发应对新型变异病毒的能力,以期在今秋生产第二代疫苗。

法国巴斯德研究所3月18日发表的一项研究表明,B.1.351和P.1等被世卫组织密切监视的新冠病毒“关注变种”(VOC)能够在实验室中通过自然方式感染小鼠,这与最初鉴定的新冠病毒的历史株不同。

突变导致新冠病毒能够更容易突破物种屏障,这种扩展宿主和跨物种传播的潜在能力为全球抗疫增加了更多不确定性。文森特•玛赫莎勒教授表示,各国必须开始对动物开展广泛监视,以避免新冠病毒发生进化飞跃,防止情况进一步复杂化。

巴西过去一周新冠死亡数占全球26.7%

巴西各州卫生厅统计数据显示,在过去一周内,巴西新冠肺炎死亡病例达18164例。该数字占到过去一周内全球新冠肺炎死亡病例总数的26.7%,超过美国、墨西哥、意大利和俄罗斯4国的死亡病例数总和,也超过所有欧盟国家的死亡病例总数。截至当地时间3月29日,巴西累计新冠肺炎死亡病例达312206例,仅次于美国。

美国正研究放弃新冠疫苗的知识产权,让全世界国家仿制生产

白宫正在研究暂停对新冠疫苗和新冠治疗药物所拥有的知识产权,让世界上所有国家都可以仿制生产,以此来挽救全世界的生命。mRNA疫苗作为一种新科技,目前只有辉瑞和Moderna掌握,他们绝不可能公开这项技术。反而是强生公司的腺病毒载体疫苗更有可能会公开,此前在《国防生产法》的状态下,强生公司已经授权默克公司共同生产,来满足全美的疫苗需求。

香港疫苗接种最新消息!香港一长期吸烟男子接种科兴疫苗后死亡、累计13人接种疫苗后死亡

据香港东网周一(3月29日)深夜报道,再多一名市民接种疫苗后死亡。死者为一名61岁男子,是一名长期吸烟者,于本月27日因胸痛及左肩痛到大埔那打素医院急症室求医,其后转往深切治疗部接受治疗,期间突然出现心室性心跳过速及心脏骤停,抢救无效后在28日中午离世,初步死因为急性心肌梗塞。

根据资料,他曾于离世前12日(即3月16日)在沙田源禾路体育馆社区疫苗接种中心接种第一剂科兴新冠疫苗,他在接种后逗留在接种中心观察期间并没有不适纪录。

香港至今累计13人接种疫苗后死亡,当中11人接种科兴,另2人接种复必泰疫苗。

巴西副总统接种第一剂中国新冠疫苗

当地时间3月29日,巴西副总统汉密尔顿·莫朗在其社交媒体账号上发文称:“我于今日接种了第一剂克尔来福新冠疫苗,完成了作为一名巴西公民应尽的义务。期望巴西大部分民众都能够尽早接种疫苗。”克尔来福疫苗系由中国科兴公司研制,目前在巴西被广泛使用。

拜登:4月19日9成美国成年人将有资格接种新冠疫苗

美国总统拜登周一宣布,9成美国成年人将在4月19日获得接种新冠疫苗资格,与此同时也将增加疫苗接种据点,让90%民众能在住家5英里范围内获得注射。

除了宣布到4月19日时,90%的美国成年人将能接种疫苗外,拜登也宣布接种的据点将从现在的1.7万个增加到近4万个,并将在未来3周再增加12个联邦运作的大型疫苗接种据点,让9成接种者能在住所5英里范围内获得注射。

他呼吁各州恢复要求民众在公共场合戴口罩,也认为重新开放的州应当暂停开放。他并呼吁所有人尽一己之力,勤洗手、保持社交距离并戴上口罩、接种疫苗。

巴基斯坦总统新冠检测呈阳性

巴基斯坦总统阿里夫·阿尔维29日晚通过社交网络宣布,其新冠病毒核酸检测结果呈阳性。另据当地媒体报道,巴基斯坦国防部长佩尔韦兹·哈塔克当天也确诊感染新冠肺炎。

巴基斯坦近来疫情持续恶化,新冠病毒核酸检测阳性率已连续5日超过10%。国家健康服务、管理和协调部29日发布的疫情数据显示,该国28日新增确诊病例4525例,新增死亡病例41例,新增治愈出院病例2268例,完成核酸检测40369人次。截至28日,巴基斯坦累计确诊病例659116例,累计死亡病例14256例,累计治愈出院病例598197例,累计完成核酸检测10107095人次。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-10-31 respect
  2. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-03-30 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-03-30 1e0edfdfm63(暂无匿称)

    太赞了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-03-30 ms7000002138112747

    决战到底

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-03-30 大白兔染染

    厉害了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2046773, encodeId=7b102046e73e3, content=<a href='/topic/show?id=ed2193101cb' target=_blank style='color:#2F92EE;'>#跨物种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93101, encryptionId=ed2193101cb, topicName=跨物种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun Oct 31 20:50:13 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029304, encodeId=5ea910293044c, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Mar 30 10:50:13 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952318, encodeId=f384952318b2, content=太赞了, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8991940501, createdName=1e0edfdfm63(暂无匿称), createdTime=Tue Mar 30 10:08:33 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952301, encodeId=c61d95230176, content=决战到底, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22155455238, createdName=ms7000002138112747, createdTime=Tue Mar 30 09:44:30 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952281, encodeId=a4799522814e, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3d85474729, createdName=大白兔染染, createdTime=Tue Mar 30 08:42:19 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952280, encodeId=aa9b952280f8, content=长期斗争, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210416/63ad7921535a46e793fc2b5377a539a7/1def2b169ab84693982a3100c8eba665.jpg, createdBy=59f35474720, createdName=ms8000000973263526, createdTime=Tue Mar 30 08:41:37 CST 2021, time=2021-03-30, status=1, ipAttribution=)]
    2021-03-30 ms8000000973263526

    长期斗争

    0

相关资讯

JAMA:头盔通气对新冠肺炎患者呼吸支持天数的影响

对于存在中重度低氧血症的新冠肺炎患者,无创头盔通气治疗在降低插管率及缩短侵入性机械通气天数方面优于单纯高流量鼻氧治疗,但总体呼吸支持天数方面差异不显著

2021年3月26日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2602万,北京接种新冠疫苗1333万剂次

Worldometers世界实时统计数据显示,截至北京时间2021年3月26日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12602万例,新增602,204例,达到126,028,33

2021年3月29日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2741万,直布罗陀超过90%人口接种新冠疫苗,已无疫情

Worldometers世界实时统计数据显示,截至北京时间2021年3月29日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12741万例,新增466,620例,达到127,741,26

2021年3月25日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2532万,中国疫苗接种日近300万剂

Worldometers世界实时统计数据显示,截至北京时间2021年3月25日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12532万例,新增529,360例,达到125,329,17

难忍新冠后遗症,美国一CEO自杀,重申新冠长远伤害!

近日,美国连锁餐厅“得克萨斯客栈”(Texas Roadhouse)的创始人兼CEO肯特·泰勒自杀身亡,享年65岁。他的遗体在其位于肯塔基州的住宅附近被发现。

2021年3月28日全球新冠肺炎(COVID-19)疫情简报,确诊超1亿2726万,以色列通过疫苗完全控制住疫情

Worldometers世界实时统计数据显示,截至北京时间2021年3月27日8时01分,全球累计确诊新冠肺炎(COVID-19)病例超过12726万例,新增567,054例,达到127,260,26

Baidu
map
Baidu
map
Baidu
map